APA (7th ed.) Citation

Messina, R., Huessler, E., Puledda, F., Haghdoost, F., Lebedeva, E. R., & Diener, H. (2023). Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis. Cephalalgia, 43(3), 1. https://doi.org/10.1177/03331024231152169

Chicago Style (17th ed.) Citation

Messina, Roberta, Eva-Maria Huessler, Francesca Puledda, Faraidoon Haghdoost, Elena R. Lebedeva, and Hans-Christoph Diener. "Safety and Tolerability of Monoclonal Antibodies Targeting the CGRP Pathway and Gepants in Migraine Prevention: A Systematic Review and Network Meta-analysis." Cephalalgia 43, no. 3 (2023): 1. https://doi.org/10.1177/03331024231152169.

MLA (9th ed.) Citation

Messina, Roberta, et al. "Safety and Tolerability of Monoclonal Antibodies Targeting the CGRP Pathway and Gepants in Migraine Prevention: A Systematic Review and Network Meta-analysis." Cephalalgia, vol. 43, no. 3, 2023, p. 1, https://doi.org/10.1177/03331024231152169.